Ledger.Open graph →

SEC Form D · Amendment · filed February 7, 2017

Banyan Biomarkers, Inc

Offering

$12.0M

Sold

$11.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

San Diego, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Nancy Denslow, Ph.D · San Diego, CADirector Henry Nordhoff · San Diego, CAExec · Director Tony Grover · San Diego, CAExec William Roper, Jr · San Diego, CADirector Ronald Hayes, Ph.D · San Diego, CAExec · Director · Promoter Andrew Von Eschenbach, M.D · San Diego, CADirector Julie Pashkowsky · San Diego, CAExec Jackson Streeter, M.D · San Diego, CAExec · Director Steven Richieri · San Diego, CAExec · Director Stanford Warshawsky · San Diego, CADirector Ben Malka · San Rafael, CADirector Heiner Dreismann · Seattle, WAExec Stephen Rose · Seattle, WADirector Michael Flaherty · Los Angeles, CAExec · Director Allan Stephan · Seattle, WADirector Peter B. Finn, Esq · Boston, MAExec · Director Isaac K. Blech · Cambridge, MAExec · Director Darin Glatt · Portland, ORExec Harold Kawaguchi · Seattle, WAExec · Director · Promoter Frederic Sweeney · San Diego, CADirector Herbert Boyer · San Diego, CADirector Marcus K. Semones, Ph.D · Cambridge, MAExec · Director Peter K. Farrell, Ph.D · Cambridge, MAExec · Director Xiaoqing Xu · Central, Hong KongDirector Tyler Mckinley · Portland, ORExec · Director David M. Klubert · Huntsville, ALDirector Dominik M. Aronsky · Huntsville, ALExec James B. Kelly · Huntsville, ALExec · Director · Promoter William Nelson, Jr · San Rafael, CADirector Scott Winters · San Rafael, CAExec Will K. Young · Las Vegas, NVDirector Frederic Sweeney · San Diego, CADirector Herbert Boyer · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗